Literature DB >> 12456963

Synergistic and inhibitory interactions in the in vitro control of murine megakaryocyte colony formation.

Donald Metcalf1, Ladina Di Rago, Sandra Mifsud.   

Abstract

The formation of megakaryocyte colonies in agar cultures of murine bone marrow or spleen cells can be stimulated by the addition of interleukin-3 (IL-3), erythropoietin (EPO), thrombopoietin (TPO), or IL-6. However, greater numbers of colonies developed if combinations of two or more of these stimuli were used, particularly combinations including stem cell factor, with maximal numbers of colonies developing with the combination of stem cell factor plus IL-3 plus EPO. The data indicate that most committed progenitor cells in the megakaryocyte lineage were unusual in that they required stimulation by two or more hematopoietic growth factors. In tests using a range of growth factors, G-CSF was exceptional in that it consistently specifically inhibited megakaryocyte colony formation stimulated by EPO, TPO, or IL-6 but not that stimulated by IL-3. The mechanisms involved in this inhibitory action of G-CSF are unknown, but the inhibitory action could be of relevance for the dose-dependent lowering of platelet levels observed in some subjects injected with G-CSF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456963     DOI: 10.1002/stem.200552

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  8 in total

Review 1.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

2.  A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation.

Authors:  Hongsheng Wang; Ming Yan; Jiafang Sun; Shweta Jain; Ryusuke Yoshimi; Sanaz Momben Abolfath; Keiko Ozato; William G Coleman; Ashley P Ng; Donald Metcalf; Ladina DiRago; Stephen L Nutt; Herbert C Morse
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

Review 3.  The colony-stimulating factors and cancer.

Authors:  Donald Metcalf
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

4.  MYC levels govern hematopoietic tumor type and latency in transgenic mice.

Authors:  Darrin P Smith; Mary L Bath; Donald Metcalf; Alan W Harris; Suzanne Cory
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

5.  Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.

Authors:  Stephen L Nutt; Donald Metcalf; Angela D'Amico; Matthew Polli; Li Wu
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

6.  PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis.

Authors:  Aleksandar Dakic; Donald Metcalf; Ladina Di Rago; Sandra Mifsud; Li Wu; Stephen L Nutt
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

7.  Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study.

Authors:  Lenar Yessayan; Jerry Yee; Gary Zasuwa; Stan Frinak; Anatole Besarab
Journal:  BMC Nephrol       Date:  2014-07-19       Impact factor: 2.388

8.  Cytokine Combinations wERKing to a Different Tune.

Authors:  David G Kent
Journal:  Hemasphere       Date:  2021-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.